JP2010512160A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010512160A5 JP2010512160A5 JP2009540888A JP2009540888A JP2010512160A5 JP 2010512160 A5 JP2010512160 A5 JP 2010512160A5 JP 2009540888 A JP2009540888 A JP 2009540888A JP 2009540888 A JP2009540888 A JP 2009540888A JP 2010512160 A5 JP2010512160 A5 JP 2010512160A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- host cell
- protein
- library
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 150000007523 nucleic acids Chemical class 0.000 claims 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 3
- 101000081248 MUC3A Proteins 0.000 claims 2
- 102000037240 fusion proteins Human genes 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 102000021340 human MUC3A protein Human genes 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
Claims (10)
- 配列番号７６の核酸によりコードされる改変ヒトＭＵＣ３タンパク質。
- 配列番号７６の核酸によりコードされる改変ヒトＭＵＣ３タンパク質とアンカー部分とが結合したタンパク質。
- アンカー部分が、グリコシル−ホスファチジル−イノシトール（ＧＰＩ）ペプチドアンカーである、請求項２に記載のタンパク質。
- 配列番号７６の核酸を含有する宿主細胞。
- 宿主細胞が酵母細胞である、請求項４に記載の宿主細胞。
- ストーク部分として配列番号７６の核酸によりコードされるポリペプチドの配列を含む融合タンパク質を複数含むライブラリー。
- ライブラリーが酵母細胞を用いたものである、請求項６に記載のライブラリー。
- 配列番号７６の核酸を含むベクター。
- 配列番号７６の核酸を宿主細胞にて発現させることにより、配列番号７６の核酸によりコードされるポリペプチドの配列を含む融合タンパク質を産生する方法。
- 宿主細胞が酵母細胞である、請求項９に記載の産生方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93495106P | 2006-12-12 | 2006-12-12 | |
| US60/934,951 | 2006-12-12 | ||
| PCT/IB2007/003908 WO2008072075A2 (en) | 2006-12-12 | 2007-12-07 | Transferrin fusion protein libraries |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010512160A JP2010512160A (ja) | 2010-04-22 |
| JP2010512160A5 true JP2010512160A5 (ja) | 2012-08-30 |
| JP5492563B2 JP5492563B2 (ja) | 2014-05-14 |
Family
ID=39362844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009540888A Expired - Fee Related JP5492563B2 (ja) | 2006-12-12 | 2007-12-07 | トランスフェリン融合タンパク質ライブラリー |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8822639B2 (ja) |
| EP (2) | EP2114999A2 (ja) |
| JP (1) | JP5492563B2 (ja) |
| KR (1) | KR20090098880A (ja) |
| CN (1) | CN101622274A (ja) |
| AU (1) | AU2007331195A1 (ja) |
| CA (1) | CA2673085C (ja) |
| ES (1) | ES2535358T3 (ja) |
| IL (1) | IL198815A0 (ja) |
| MX (1) | MX2009006398A (ja) |
| NO (1) | NO20092591L (ja) |
| WO (1) | WO2008072075A2 (ja) |
| ZA (1) | ZA200904757B (ja) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8401798B2 (en) * | 2008-06-06 | 2013-03-19 | Dna Twopointo, Inc. | Systems and methods for constructing frequency lookup tables for expression systems |
| EP4089169A1 (en) | 2009-10-12 | 2022-11-16 | Larry J. Smith | Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
| CN102258767B (zh) * | 2010-05-24 | 2013-05-15 | 黄敏铨 | 促进伤口愈合的组合物 |
| US20130251740A1 (en) * | 2010-10-26 | 2013-09-26 | Rockefeller University (The) | Immunogenic agents |
| EP2670421B1 (en) * | 2011-02-02 | 2017-12-06 | Medipost Co., Ltd. | Use of icam-1 for prevention or treatment of neurological diseases |
| US9623117B2 (en) * | 2011-04-04 | 2017-04-18 | Wisconsin Alumni Research Foundation | Method for selective targeting and entry of bacterial toxins to cells |
| US9296801B2 (en) | 2012-06-08 | 2016-03-29 | Alkermes, Inc. | Fusion polypeptides comprising mucin-domain polypeptide linkers |
| WO2014093357A1 (en) * | 2012-12-10 | 2014-06-19 | The University Of Queensland | Cell-free biofragment compositions and related systems, devices, and methods |
| US10829771B2 (en) * | 2014-11-10 | 2020-11-10 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for expressing polypeptides on the surface of cells |
| JP6991126B2 (ja) * | 2016-03-30 | 2022-01-12 | 株式会社カネカ | エンドヌクレアーゼ活性を有するポリペプチド及びその製造方法 |
| US11512135B2 (en) * | 2016-08-25 | 2022-11-29 | Jcr Pharmaceuticals Co., Ltd. | Method for producing antibody fusion protein |
| JP2022515150A (ja) * | 2018-12-21 | 2022-02-17 | フエー・イー・ベー・フエー・ゼツト・ウエー | サイトカイン及び足場タンパク質を含む融合タンパク質 |
| CN113045670B (zh) * | 2019-12-27 | 2022-11-01 | 华南农业大学 | 一种可溶性鸡α干扰素融合蛋白及其生产方法与应用 |
| WO2023114912A2 (en) * | 2021-12-16 | 2023-06-22 | Thomas Jefferson University | A therapeutic against crimean-congo hemorrhagic fever virus |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599311A (en) | 1982-08-13 | 1986-07-08 | Kawasaki Glenn H | Glycolytic promotersfor regulated protein expression: protease inhibitor |
| US4703004A (en) | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
| US4782137A (en) | 1984-01-24 | 1988-11-01 | Immunex Corporation | Synthesis of protein with an identification peptide, and hybrid polypeptide incorporating same |
| AU600885B2 (en) | 1984-05-25 | 1990-08-30 | Zymogenetics Inc. | Stable DNA constructs |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5026651A (en) | 1985-04-25 | 1991-06-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the production of human transferrin |
| US4851341A (en) | 1986-12-19 | 1989-07-25 | Immunex Corporation | Immunoaffinity purification system |
| US5011912A (en) | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
| US6018026A (en) | 1988-01-22 | 2000-01-25 | Zymogenetics, Inc. | Biologically active dimerized and multimerized polypeptide fusions |
| US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
| US5346989A (en) | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
| US5347849A (en) | 1990-08-30 | 1994-09-20 | Tanknology Corporation International | Water sensor that detects tank or vessel leakage |
| US5986067A (en) | 1991-02-08 | 1999-11-16 | The University Of Vermont And State Agricultural College | Recombinant transferrins, transferrin half-molecules and mutants thereof |
| CA2122717C (en) | 1991-11-08 | 2003-07-15 | David C. Anderson | Hemoglobins as drug delivery agents |
| AU688733B2 (en) | 1992-07-20 | 1998-03-19 | Duke University | Compounds which inhibit HIV replication |
| US5547871A (en) | 1993-01-25 | 1996-08-20 | American Cyanamid Company | Heterologous signal sequences for secretion of insect controlling proteins |
| US6955900B1 (en) * | 1993-02-02 | 2005-10-18 | The Scripps Research Institute | Methods for producing polypeptide binding sites, monoclonal antibodies and compositions thereof |
| EP0682710B1 (en) | 1993-02-10 | 2003-10-29 | Unilever Plc | Isolation process using immobilized proteins with specific binding capacities |
| WO1994017810A1 (en) | 1993-02-12 | 1994-08-18 | The Wistar Institute Of Anatomy And Biology | Recombinant cytomegalovirus vaccine |
| EP0708658A4 (en) | 1993-04-16 | 1997-05-21 | Wistar Inst | VACCINE CONTAINING A RECOMBINANT CYTOMEGALOVIRUS |
| US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
| US6017536A (en) | 1993-06-07 | 2000-01-25 | Trimeris, Inc. | Simian immunodeficiency virus peptides with antifusogenic and antiviral activities |
| US5464933A (en) | 1993-06-07 | 1995-11-07 | Duke University | Synthetic peptide inhibitors of HIV transmission |
| US5603933A (en) | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
| US5981478A (en) * | 1993-11-24 | 1999-11-09 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
| US5516637A (en) | 1994-06-10 | 1996-05-14 | Dade International Inc. | Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage |
| US5843882A (en) | 1995-04-27 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides |
| US5817789A (en) | 1995-06-06 | 1998-10-06 | Transkaryotic Therapies, Inc. | Chimeric proteins for use in transport of a selected substance into cells |
| EP0831873A4 (en) | 1995-06-07 | 2002-07-17 | Trimeris Inc | COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS |
| US6696251B1 (en) | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6300065B1 (en) | 1996-05-31 | 2001-10-09 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6699658B1 (en) | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6759243B2 (en) | 1998-01-20 | 2004-07-06 | Board Of Trustees Of The University Of Illinois | High affinity TCR proteins and methods |
| US6258782B1 (en) | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| US6699677B1 (en) * | 1999-12-20 | 2004-03-02 | Chemocentryx, Inc. | Tethered ligands and methods of use |
| US6623741B1 (en) | 2000-02-29 | 2003-09-23 | Trimeris, Inc. | Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission |
| AU2001266557A1 (en) | 2000-04-12 | 2001-10-23 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7176278B2 (en) | 2001-08-30 | 2007-02-13 | Biorexis Technology, Inc. | Modified transferrin fusion proteins |
| US20070031440A1 (en) | 2001-08-30 | 2007-02-08 | Prior Christopher P | Modified transferin-antibody fusion proteins |
| US20030226155A1 (en) | 2001-08-30 | 2003-12-04 | Biorexis Pharmaceutical Corporation | Modified transferrin-antibody fusion proteins |
| DE60238541D1 (de) | 2001-08-30 | 2011-01-20 | Biorexis Pharmaceutical Corp | Modifizierte transferrin-fusionsproteine |
| AU2003270009A1 (en) | 2002-08-30 | 2004-03-19 | Biorexis Pharmaceutical Corporation | Oral delivery of modified transferrin fusion proteins |
| DK1539221T3 (da) * | 2002-08-30 | 2010-05-03 | Biorexis Pharmaceutical Corp | Transferrin-fusionsproteinbiblioteker |
| ES2347144T3 (es) | 2002-08-30 | 2010-10-26 | Biorexis Pharmaceutical Corporation | Proteinas de fusion de la transferrina modificada que comprenden dominos aino o carboxilo de transferrina duplicados. |
| US20060105387A1 (en) | 2002-08-30 | 2006-05-18 | Prior Christopher P | Transferrin fusion proteins libraries |
| EP1626981A4 (en) | 2003-03-04 | 2006-11-22 | Biorexis Pharmaceutical Corp | PROTEINS PROTECTED AGAINST DIPEPTIDYLPEPTIDASE |
| US20070060512A1 (en) | 2003-03-04 | 2007-03-15 | Homayoun Sadeghi | Dipeptidyl-peptidase protected protein |
| EP1663278A4 (en) | 2003-08-28 | 2009-07-29 | Biorexis Pharmaceutical Corp | EPO MIMETIC PEPTIDES AND FUSION PROTEINS |
| US20060205037A1 (en) | 2003-08-28 | 2006-09-14 | Homayoun Sadeghi | Modified transferrin fusion proteins |
| WO2006049983A2 (en) | 2004-10-27 | 2006-05-11 | Biorexis Pharmaceutical Corporation | Peptide yy modified transferrin fusion proteins |
| CA2599723A1 (en) | 2005-03-04 | 2006-09-14 | Biorexis Pharmaceutical Corporation | Modified transferrin fusion proteins |
| JP2008546392A (ja) * | 2005-06-17 | 2008-12-25 | バイオレクシス ファーマシューティカル コーポレーション | 固定されたトランスフェリン融合タンパク質ライブラリー |
| KR101193722B1 (ko) | 2006-07-24 | 2013-01-11 | 바이오렉시스 파마슈티칼 코포레이션 | 엑센딘 융합 단백질 |
-
2007
- 2007-12-07 MX MX2009006398A patent/MX2009006398A/es unknown
- 2007-12-07 AU AU2007331195A patent/AU2007331195A1/en not_active Abandoned
- 2007-12-07 WO PCT/IB2007/003908 patent/WO2008072075A2/en active Application Filing
- 2007-12-07 CN CN200780050623A patent/CN101622274A/zh active Pending
- 2007-12-07 JP JP2009540888A patent/JP5492563B2/ja not_active Expired - Fee Related
- 2007-12-07 CA CA2673085A patent/CA2673085C/en not_active Expired - Fee Related
- 2007-12-07 KR KR1020097014465A patent/KR20090098880A/ko not_active Application Discontinuation
- 2007-12-07 EP EP07859040A patent/EP2114999A2/en active Pending
- 2007-12-07 US US12/517,855 patent/US8822639B2/en not_active Expired - Fee Related
- 2007-12-07 EP EP12157790.2A patent/EP2479189B1/en not_active Not-in-force
- 2007-12-07 ES ES12157790.2T patent/ES2535358T3/es active Active
-
2009
- 2009-05-19 IL IL198815A patent/IL198815A0/en unknown
- 2009-07-07 NO NO20092591A patent/NO20092591L/no not_active Application Discontinuation
- 2009-07-07 ZA ZA200904757A patent/ZA200904757B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010512160A5 (ja) | ||
| JP2009268467A5 (ja) | ||
| JP2018532705A5 (ja) | ||
| JP2006036784A5 (ja) | ||
| JP2012095652A5 (ja) | ||
| WO2008104890A3 (en) | Compositions and methods for producing apolipoprotein | |
| JP2016527891A5 (ja) | ||
| JP2005120106A5 (ja) | ||
| JP2011062217A5 (ja) | ||
| JP2010529860A5 (ja) | ||
| WO2010037836A3 (en) | Cross-species-specific psmaxcd3 bispecific single chain antibody | |
| JP2011182800A5 (ja) | ||
| JP2009534043A5 (ja) | ||
| EP2351834A3 (en) | Production of biologically active proteins | |
| WO2008119567A8 (en) | Cross-species-specific cd3-epsilon binding domain | |
| BRPI0820613A2 (pt) | Polipeptídeo isolado, construção de ácido nucléico, célula hospedeira recombinante, métodos de produzir o polipeptídeo, de produzir um mutante de uma célula precursora, de inibir a expressão de um polipeptídeo tendo atividade de endoglicanase em uma célula, de degradar ou converter um material celulósico, de produzir um produto de fermentação e de produzir uma proteína, planta transgênica, parte de planta ou célula vegetal, molécula de rna inibidora de filamento duplo, construção de ácido nucléico, e, célula hospedeira recombinante | |
| JP2011500077A5 (ja) | ||
| JP2018528237A5 (ja) | ||
| EP2728004A3 (en) | Bacterial toxin vaccine | |
| WO2010132341A3 (en) | Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein | |
| RU2007124377A (ru) | Выделение и очистка белка | |
| WO2014097113A3 (en) | Production of therapeutic proteins in genetically modified mammalian cells | |
| JP2009142259A5 (ja) | ||
| EA200700233A1 (ru) | Новая последовательность для повышения экспрессии нуклеиновой кислоты | |
| CN104402975B (zh) | 抗衰老短肽及其制备方法 |